Francesco Agustoni

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

Marina Chiara Garassino, Jennifer G. Whisenant, Li‐Ching Huang et al. · The Lancet Oncology · 2020 · 624 citations · Full text

Medicine, Oncology, Clinical Epidemiology +3

A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin

Paolo Bossi, Diego Cortinovis, Sonia Fatigoni et al. · Annals of Oncology · 2017 · 85 citations · Full text

Medicine, Oncology, Pharmacology +15

Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions

Riccardo Gerosa, Rita De Sanctis, Flavia Jacobs et al. · Critical Reviews in Oncology/Hematology · 2024 · 76 citations · Full text

Medicine, Cancer Biology, Oncology +17

A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer

Alessio Bruni, Vieri Scotti, Paolo Borghetti et al. · Frontiers in Oncology · 2021 · 49 citations · Full text

Medicine, Oncology, Radiation Oncology +16

A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study

Angioletta Lasagna, Francesco Agustoni, Elena Percivalle et al. · ESMO Open · 2021 · 43 citations · Full text

Medicine, Immunology, Oncology +17